5-[2-(6-methyl-2,3-dihydro-4H-1,4-benzoxazin-4-yl)-2-oxoethyl]-3-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]-3,5-dihydro-4H-pyrimido[5,4-b]indol-4-one
Chemical Structure Depiction of
5-[2-(6-methyl-2,3-dihydro-4H-1,4-benzoxazin-4-yl)-2-oxoethyl]-3-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]-3,5-dihydro-4H-pyrimido[5,4-b]indol-4-one
5-[2-(6-methyl-2,3-dihydro-4H-1,4-benzoxazin-4-yl)-2-oxoethyl]-3-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]-3,5-dihydro-4H-pyrimido[5,4-b]indol-4-one
Compound characteristics
| Compound ID: | L690-0176 |
| Compound Name: | 5-[2-(6-methyl-2,3-dihydro-4H-1,4-benzoxazin-4-yl)-2-oxoethyl]-3-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]-3,5-dihydro-4H-pyrimido[5,4-b]indol-4-one |
| Molecular Weight: | 470.49 |
| Molecular Formula: | C25 H22 N6 O4 |
| Smiles: | [H]c1ccc2c(c1)c1c(C(N(Cc3nc(C)no3)C=N1)=O)n2CC(N1CCOc2ccc(C)cc12)=O |
| Stereo: | ACHIRAL |
| logP: | 2.3731 |
| logD: | 2.3731 |
| logSw: | -2.8945 |
| Hydrogen bond acceptors count: | 9 |
| Polar surface area: | 79.164 |
| InChI Key: | SLACIZWXNLERJD-UHFFFAOYSA-N |